ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $150,000 | -74.1% | 2,618 | -71.3% | 0.03% | -81.2% |
| Q1 2015 | $580,000 | +58.0% | 9,124 | -3.5% | 0.14% | +188.0% |
| Q3 2014 | $367,000 | +28.3% | 9,453 | +13.7% | 0.05% | +11.1% |
| Q2 2014 | $286,000 | +1806.7% | 8,313 | +1978.2% | 0.04% | +400.0% |
| Q3 2013 | $15,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |